P&G Likely To Keep Prilosec OTC, Vicks In Portfolio Shuffle – Analysts

P&G’s plan to sell half of its brands triggered speculation about what the firm will keep and what it will sell. A Bernstein analyst predicts the firm will part with many oral care products and dietary supplements, but will keep consumer health brands including Prilosec OTC, Vicks and Crest.